A patient advocacy group founded by two parents has partnered with a biotech company on a gene therapy for limb-girdle muscular dystrophy Type 2C/R5 - it was just cleared to start a clinical trial episode artwork

EPISODE · Nov 19, 2024 · 20 MIN

A patient advocacy group founded by two parents has partnered with a biotech company on a gene therapy for limb-girdle muscular dystrophy Type 2C/R5 - it was just cleared to start a clinical trial

from The Studio at Kendall Square · host BiotechTV

Dion Foundation Co-Founder and President Courtney Dion discusses with Atamyo Therapeutics CEO Stéphane Degove the many ways that patient advocate groups can support the work that biotech companies do.

Episode metadata supplied by the publisher feed · Published Nov 19, 2024

Embed this episode

Ready to play

A patient advocacy group founded by two parents has partnered with a biotech company on a gene therapy for limb-girdle muscular dystrophy Type 2C/R5 - it was just cleared to start a clinical trial

0:00 20:20

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Studio at Kendall Square?

This episode is 20 minutes long.

When was this The Studio at Kendall Square episode published?

This episode was published on November 19, 2024.

Can I download this The Studio at Kendall Square episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!